stroke systems of care v.t. doss, d.o. stroke medical director, bmh-memphis assistant professor,...
TRANSCRIPT
![Page 1: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/1.jpg)
Stroke Systems of Care
V.T. Doss, D.O.Stroke Medical Director, BMH-MemphisAssistant Professor, Neurology & Neurosurgery, UTHSC
![Page 2: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/2.jpg)
Intro
Neurological emergency Ischemic vs. Hemorrhagic TOAST classification(1) thrombosis /embolism due to atherosclerosis of a large
artery(2) cardioembolic origin(3) occlusion of a small blood vessel(4) other determined cause (CSVT, vasculitis, trauma)(5) undetermined cause (two possible causes, no cause
identified, or incomplete investigation)
![Page 3: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/3.jpg)
Memphis- the capitol of atherosclerosis?
![Page 4: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/4.jpg)
Stroke death rates, 2000–2006: adults ≥35 years of age, by county.
Writing Group Members et al. Circulation 2012;125:e2-e220
Copyright © American Heart Association
![Page 5: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/5.jpg)
US Stats 95% of strokes at age
>45, and 2/3 of strokes occur in those >65
leading cause death/disability
10% deaths worldwide 795,000 strokes/yr,
610,000 of these are first strokes. About 185,000 people who survive a stroke go on to have another
In 2010, stroke cost the US $53.9 billion
![Page 6: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/6.jpg)
According to the WHO, 15 million people suffer stroke worldwide each year.Of these, 5 million die and another 5 million are permanently disabled.
Stroke is the second single most common cause of death in Europe: accounting for almost 1.1 million deaths each year.
Over one in seven women (15%) and one in ten men (10%) die from the disease.
![Page 7: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/7.jpg)
Why is Time Important? The area peripheral to a core infarct where
metabolism is active but blood flow is diminished is called the ischemic penumbra
This is salvageable tissue that is at risk for infarction.
The penumbra lies in a 'no-man's land' between a zone of low blood flow that is < 25 ml/100 mg brain tissue/min and a zone where brain tissue is undergoing necrosis/death, flow of < 8-10 ml/100 mg/min1
Without restoration of blood flow/oxygen, the ischemic penumbra will convert to ischemic core or tissue death
1- http://medical-dictionary.thefreedictionary.com/ischemic+penumbra
BrainIschemic Penumbr
a
Core Infarct
![Page 8: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/8.jpg)
Time is Brain !!
Neurology. 2000 Dec 12;55(11):1649-55.
![Page 9: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/9.jpg)
RPCT – TPA v. Placebo < 3 hours (Dose .9mg/kg IV)Inclusion Criteria: Stroke with clear time of onset, CT without ICH, & measurable deficit on NIHSSExclusion Criteria: Recent GI or GU Bleed w/in 21 days, Ischemic stroke within 3 months,hx of ICH, recent arterial puncture at a noncompressible site w/in 7 days, SBP > 185 or DBP > 110 that can’t be controlled, INR > 1.5, platelets < 100K, glucose > 400 or < 50 Seizure at onset
Phase I (N=291): TPA clinical activity @ 24 hours NIHSS improvement of >/= 447% TPA vs. 39% placebo, p= 0.21
Phase II (N=333): Primary Outcomes (MRS < 2) at 90 days, ARR 12%, NNT = 8 SICH 6.4 % vs. 0.6 % (P < 0.001)
IV TPA APPROVED by FDA in 1996NOW THE ACCEPTED STANDARD OF CARE
THROUGHOUT US, EUROPE AND ASIA
![Page 10: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/10.jpg)
Expanded time window for milder strokes, NIHHS < 25 with less than 1/3 of MCA territory on CTN=821Primary endpoint: MRS < 2 @ 90 days. 52.4% vs. 45.2, P = 0.04
Number Needed to Treat = 14
![Page 11: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/11.jpg)
Modified Rankin Scale
0 - No symptoms. 1 - No significant disability. Able to carry out all usual
activities, despite some symptoms. 2 - Slight disability. Able to look after own affairs
without assistance, but unable to carry out all previous activities.
3 - Moderate disability. Requires some help, but able to walk unassisted.
4 - Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted.
5 - Severe disability. Requires constant nursing care and attention, bedridden, incontinent.
6 - Dead.
![Page 12: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/12.jpg)
NINDS NINDS randomized 624 subjects within 3 hours of stroke onset to
receive 0.9 mg/kg of intravenous tPA or placebo found that patients treated with tPA within 3 hours of onset had a
substantially better chance of functional independence with minimal or no disability 3 months after treatment
The proportion of patients with minimal or no disability increased from 38% with placebo to 50% with tPA, a 12% absolute improvement
The NNT for 1 more patient to have a normal or near normal outcome was 8
NNT for 1 more patient to have an improved outcome was 3.1 Brain hemorrhages related to tPA caused severe worsened final
outcome in 1% of patients Overall, for every 100 patients treated within the first 3 hours, 32
had a better outcome as a result and 3 had a worse outcome.
![Page 13: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/13.jpg)
ECASS III
821 pts, 3-4.5 hr no difference in mortality between the two groups
(approximately 8%) sICH higher in tpa group (2.4%) odds for a favorable outcome (MRS 0-1) after stroke
were 28% higher with alteplase than with placebo Time is tissue
![Page 14: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/14.jpg)
NINDS and ACLS Recommended Benchmarks for Potential Thrombolysis Candidate
Interval Target
Door to doctor 10 min
Access to neuro expertise 15 min
Door to CT completion 25 min
Door to CT interpretation 45 min
Door to IV-rTPA 60 min
Admission to stroke unit or ICU 3 hours
![Page 15: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/15.jpg)
Casting a wider net
Expanding time window Stroke centers- primary,
comprehensive Tele-stroke Multi-modal imaging New agents/devices Less is more? Neuroprotection
![Page 16: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/16.jpg)
Direction/Innovations
EMS Advances Telemedicine Spoke and
Hub Models
![Page 17: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/17.jpg)
![Page 18: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/18.jpg)
Tele-Stroke 24hr access to
neuro specialist Avoids stroke
mimickers Allows smaller
hospitals to keep these patients
![Page 19: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/19.jpg)
CSCPhysicians Vascular Neurology Vascular Neurosurgery Vascular Surgery Diagnostic radiology and neuroradiology Interventional/endovascular physicians Critical care medicine Physiatrists
Surgical and interventional therapies CEA Intracranial aneurysm clipping Surgical removal or draining of blood
from the brain Placement of EVD and intracranial
pressure monitors Endovascular treatment
of aneurysms and arteriovenous malformations
Intra-arterial reperfusion therapy Endovascular treatment of vasospasm
Infrastructure• Stroke Unit• Intensive Care Unit• Operating room staffed 24/7• Interventional staff available 24/7• Stroke registry
Diagnostic techniques• MRI with diffusion• MRA and MRV• Computed Tomography Angiogram (CTA)• Digital cerebral angiography• Transcranial dopplers• Carotid duplex ultrasound• TTE and TEE
Rehabilitation (PT/OT/ST)Advanced Practice Nursing /Staff stroke nursesRespiratory Therapists
Educational/research programs• Clinical research• Community education/prevention• Professional education
![Page 20: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/20.jpg)
Mobile Stroke Unit
Point-of-Care-based laboratory compact CT scan results, reviewed
remotely by hospital physicians results in early pre-hospital IV-
thrombolysis and subsequent bridging therapy later with IA recanalization in the hospital
![Page 21: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/21.jpg)
Options for Patients Experiencing an Ischemic Stroke
Endovascular Clot Removal
Mechanical disruption or removal of the clot using standard endovascular
approaches
IV tPAGold-standard in ischemic
stroke care. Drug is designed to break apart
the clot.
Medical Management
Monitor vitals and provide secondary stroke
prevention. Patient is send to rehab or a
nursing facility when stable.
Bridging Therapy
![Page 22: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/22.jpg)
Endovascular Therapy
Anterior 12 hours Posterior <24h NIHSS >7 Evidence of Large vessel occlusion,
hemodynamically unstable Large penumbra or clinical mismatch
![Page 23: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/23.jpg)
Recanalization rate IV TPA: M1: 22%, M2:44%‡
Mortality:
25% vs 42.9%##
Recanalization rate with IV TPA: <10%
Mortality: 73%(persistent occlusion)^^
MCA Occlusion
Internal Carotid Occlusion
Basilar OcclusionRecanalization rate with IV TPA: <10%
Mortality: 90%(persistent occlusion)**
‡Alexandrov et al. Stroke ## Proact II: Jama 1999
**Meta analysis Furlan et al
^^ Flint et al. MERCI Registry Stroke 2008
![Page 24: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/24.jpg)
The Importance of Recanalization
Recanalization is strongly associated with improved
function outcomes and reduced mortality.
![Page 25: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/25.jpg)
Meta-analysis shows a strong correlation between opening the blood vessel and patient good outcomes
Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke. 2007 Mar;38(3):967-73.
58.1%
14.4% 13.7%
24.8%
41.6%
12.5%
0%
10%
20%
30%
40%
50%
60%
70%
Good Outcome(mRS 0-2)
90-Day Mortality SICH
% of
Pati
ents
Revascularized Non-revascularized
![Page 26: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/26.jpg)
Clinical Trials
Most recent published EVT (endovascular therapy) trial results
Lessons learned Current trial design
![Page 27: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/27.jpg)
New EVT Stroke Trials
IMS IIIMR RESCUESYNTHESIS - EXPANSION
NEJM February 7, 2013
![Page 28: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/28.jpg)
IMS III
![Page 29: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/29.jpg)
IMS III: Interventional Management of Stroke 3
Patients who had received intravenous rt-PA within 3 hours after symptom onset were randomized 2:1 to: IV tPA + IA therapy IV t-PA alone
Primary outcome measure: 90-day mRS ≤ 2
Broderick JP. NEJM 2013;368:893-903
![Page 30: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/30.jpg)
Primary outcome: IMS III
mRS < 2 95% CI: -6.1% to +9.1% 40.8% with endovascular + IV rt-
PA38.7% with IV rt-PA alone
Broderick JP. NEJM 368: 893-903, 2013
![Page 31: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/31.jpg)
MR RESCUE
![Page 32: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/32.jpg)
MR RESCUE: Methods
≤ 8 hours of onset Anterior circulation LVO Randomized to either EVT or
Medical Mgmt “penumbral” pattern by CT or MRI
Penumbra : “Small core” (<90 cc), large penumbra
Non-Penumbral: Large core and small/absent penumbra
Kidwell CS. NEJM 2013 Mar 7;368(10):914-23
![Page 33: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/33.jpg)
MR RESCUE: 90-day mRS
NO DIFFERENCE IN OUTCOMES Endovascular vs. medical therapy Penumbra vs. no penumbra
p=0.23
p=0.32
Kidwell CS. NEJM 368: 914-23, 2013
![Page 34: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/34.jpg)
Synthesis Expansion
![Page 35: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/35.jpg)
Synthesis Expansion: Outcomes
Primary Outcome (mRS < 1) 30.4% EVT 34.8% IV tPA
Death Rates EVT: 14 (8%) IV tPA: 11 (6%)
“EVT is not superior to standard treatment with IV tPA”
Italian Medicines Agency (AIFA)
Ciccone A. NEJM 368: 904-13, 2013
![Page 36: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/36.jpg)
IMS III Protocol Versus Contemporary Practice
The majority of patients included in the study Were not imaged using modern approaches Were not triaged using modern approaches Were not treated using modern approaches
![Page 37: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/37.jpg)
Basic Head CT only in most patientsMore than 40% of IMS III patients had baseline CT
with ASPECTS < 7
Imaging Assessment
![Page 38: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/38.jpg)
ASPECTS (Alberta Stroke Program Early CT Score)
![Page 39: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/39.jpg)
ASPECTS Score - 4
![Page 40: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/40.jpg)
Patient Selection Matters: Penumbra Pivotal Trial
Small Infarct
15/30 pts
Large Infarct
8/53 pts Goyal M. Stroke 2010
Independent Blinded Retrospective AnalysisBaseline NCCT Data Using ASPECTS
mRS ≤ 2
![Page 41: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/41.jpg)
IMS III - Imaging Assessment
Patients with “large clear regions of hypodensity” (darker than white matter and brighter than CSF) on CT, greater than 1/3rd of MCA territory were excluded Sulcal effacement and loss of grey-white matter
differentiation were not contraindications Many patients would have likely been excluded with more
conservative CT reading (ASPECTS), CTA-SI (source image) ASPECTS, MR Diffusion ASPECTS, CT Perfusion or MR Perfusion
![Page 42: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/42.jpg)
Imaging Based Selection:Perfusion Imaging
![Page 43: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/43.jpg)
89 patients with ”no treatable or treated thrombus” 33 no thrombus seen 34 thrombus not treatable by EVT 12 with treatable thrombus but not treated
No reason (1)Couldn’t safely cross occlusion (3)Recanalization during angio (2)Occlusion not responsible for clinical
presentation (2)No reason (2)
Would ALL have been screened out with CTA
IMS III – EVT Arm
![Page 44: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/44.jpg)
43% of large vessel occlusions have greater than 8 mm clot lengths1
Clot characteristics (length)
No Clot > 8mm recanalized with IV tPA
![Page 45: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/45.jpg)
IMS III: Baseline CTA Occlusion Present – 90 day mRS
van Elteren test p-value 0.0114
![Page 46: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/46.jpg)
IMS III: Baseline CTA Occlusion Present - NIHSS > 20
van Elteren test p-value 0.0330
![Page 47: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/47.jpg)
TICI Score Grade 0 No perfusion Grade 1 Perfusion past the initial obstruction, but limited
distal branch filling with little or slow distal perfusion Grade 2a Perfusion of less than ½ of the vascular
distribution of the occluded artery (e.g., filling and perfusion through 1 M2 division)
Grade 2b Perfusion of ½ or greater of the vascular distribution of the occluded artery (e.g., filling and perfusion through 2 or more M2 divisions)
Grade 3 Full perfusion with filling of all distal branches
![Page 48: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/48.jpg)
Percentage of Patients Who Achieved a Functional Outcome in IMS III Based on Reperfusion Result (p=0.001)
In IMS III, independent functional outcome (mRS 0-2) was strongly associated with TICI 2b-3 revascularization.
![Page 49: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/49.jpg)
Total endovascular treatments = 334/434 IA tPA 138 EKOS + tPA 22 Merci 38 Merci + tPA 57 Penumbra 16 Penumbra + tPA 38 Solitaire 2 Solitaire + tPA 3
‘modern’ devices = 13% of endovascular cohort
IMS III
![Page 50: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/50.jpg)
IMS III
IMS-III endovascular reperfusion rates:≥ TICI 2a ≥ TICI 2b
ICA 65% 38%M1 81% 44%M2 77% 44%Overall 70% 40%
TREVO2* 92% 68%SWIFT* 94% 76%
*Both are high quality independent core lab adjudicated, published in Lancet
![Page 51: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/51.jpg)
Systems and Process Issues in the Era of Comprehensive Stroke Center Designation
Relative to IMS I and II, the IMS III trial suffered from a dramatic delay between the initiation of iv tPA and endovascular therapy
At over two hours, this lag impedes the ability of reperfusion to realize clinical benefit.
![Page 52: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/52.jpg)
IMS III patients further suffered a significant lag between groin access and initiation of IAT at the lesion Fourty-four minutes is far beyond reported standards with modern guide and distal access catheter technology
![Page 53: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/53.jpg)
Time to Treatment
IMS III Onset to arrival: 57 min Arrival to IV tPA: 66 min IV to groin puncture: 86 mins Groin puncture to IA: 44 mins
MR RESCUE Mean time from imaging to groin puncture:
2h 4 min SYNTHESIS
Time from onset to start of treatment EVT 3.75 hrs IV 2.75 hrs
130 mins between IV tPA and start of IA therapy By comparison STAR
registry:Groin Puncture to guide cath placement: 12 minsGuide cath to TICI 2B/3 flow: 20 mins
Critical as IA group did NOT receive IV tpa
![Page 54: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/54.jpg)
Lessons LearnedEndovascular Therapy is safe – as safe as IV rt-PA
![Page 55: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/55.jpg)
Lessons Learned from Recent Ischemic Stroke Trials
It is not IV vs EVT IV tPA is proven Class 1 – it should not be denied from patients Future trials should compare best medical management versus best
medical management + EVT Only enroll patients with LVO (large vessel occlusion) Excellent recanalization is needed
TICI 2B or 3 Time is Brain Better determination of salvageable brain tissue
ASPECTS CT Perfusion MRI Diffusion/Perfusion
![Page 56: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/56.jpg)
Merci Retriever “Cork Screw”
![Page 57: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/57.jpg)
Newer Technologies = Better Recanalization
Solitaire FR
Trevo
Separator 3-D
Penumbra Max System
![Page 58: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/58.jpg)
![Page 59: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/59.jpg)
![Page 60: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/60.jpg)
Distal aspiration with retrievable stent assisted thrombectomy for the treatment of acute ischemic strokeWilliam Humphries1, Daniel Hoit1, Vinodh T Doss1, Lucas Elijovich1, Adam S Arthur1
Abstract
Objective Flexible large lumen aspiration catheters and stent retrievers have recently become available in the USA for the revascularization of large vessel occlusions presenting within the context of acute ischemic stroke (AIS). We describe a multicenter experience using a combined aspiration and stent retrieval technique for thrombectomy.Design A retrospective analysis to identify patients receiving combined manual aspiration and stent retrieval for treatment of AIS between August 2012 and April 2013 at six high volume stroke centers was conducted. Outcome variables, including recanalization rate, post-treatment National Institutes of Health Stroke Scale (NIHSS) score, symptomatic intracranial hemorrhage, discharge 90 day modified Rankin Scale (mRS) score, and mortality were evaluated.
Results 105 patients were found that met the inclusion criteria for this retrospective study. Successful recanalization (Thrombolysis in Cerebral Infarction score 2B) was achieved in 92 (88%) of these patients. 44% of patients had favorable (mRS score 0–2) outcomes at 90 days. There were five (4.8%) symptomatic intracerebral hemorrhages and three procedure related deaths (2.9%).
Conclusions Mechanical thrombectomy utilizing combined manual aspiration with a stent retriever is an effective and safe strategy for endovascular recanalization of large vessel occlusions presenting within the context of AIS.
J NeuroIntervent Surg doi:10.1136/neurintsurg-2013-010986
![Page 61: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/61.jpg)
Case 1
53yo male presented with L MCA syndrome
NIHSS 21 Onset 1 hour Received iv-tpa within 60 min from
door
![Page 62: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/62.jpg)
Pre-treatment
![Page 63: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/63.jpg)
![Page 64: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/64.jpg)
Post-treatment
![Page 65: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/65.jpg)
Case 1
Dysfluency and hemiparesis d/c to rehab with mRS of 2 1 mo f/u mRS of 1
![Page 66: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/66.jpg)
Case 2
75yo male consulted for acute stroke Pseudobulbar palsy Post. circulation strokes 3 months
prior, d/c mRS 0, was on ASA/plavix
![Page 67: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/67.jpg)
April 2013
![Page 68: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/68.jpg)
![Page 69: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/69.jpg)
![Page 70: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/70.jpg)
![Page 71: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/71.jpg)
![Page 72: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/72.jpg)
![Page 73: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/73.jpg)
Case 3
35yo AA male presents with 2 hours of inability to produce speech and right sided weakness.
PMH: bipolar d/o
Exam: awake, not following commands, globally aphasicRight hemiplaegia
NIHSS: 22
![Page 74: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/74.jpg)
IMG_0512.MOV
![Page 75: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/75.jpg)
![Page 76: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/76.jpg)
![Page 77: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/77.jpg)
![Page 78: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/78.jpg)
![Page 79: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/79.jpg)
At Discharge: mRS- 0, NIHSS 1
![Page 80: Stroke Systems of Care V.T. Doss, D.O. Stroke Medical Director, BMH-Memphis Assistant Professor, Neurology & Neurosurgery, UTHSC](https://reader037.vdocument.in/reader037/viewer/2022110319/56649c725503460f949235ea/html5/thumbnails/80.jpg)
Conclusions Stroke systems and patient selection critical to
outcomes EMS critical to triage, stabilizing and
transporting to stroke center Imperative to recognize signs and symptoms of
stroke especially large vessel occlusion IV-TPA standard of care Endovascular treatment can be performed
quickly and safely Time is Brain!